Breakthrough CD19+ B-Cell Targeted Therapy Delivered an 87% Reduction in the Risk of Flares Versus Placebo UPLIZNA Shown to Deliver Corticosteroid-Free, Flare-Free, Complete Remission for Patients in the MITIGATE Trial Advances Amgen's Leadership in CD19 Directed, B-Cell Depletion...
Read More Details
Finally We wish PressBee provided you with enough information of ( UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE )
Also on site :
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Friday, April 4
- A Green Beret looked into divorce. Then his wife was arrested after his dismembered body was found in a pond
- Tarek El Moussa Gives Blunt Opinion on Ex Christina Haack's Relationship Status